{"Symbol": "ARTV", "AssetType": "Common Stock", "Name": "Artiva Biotherapeutics, Inc. Common Stock", "Description": "Artiva Biotherapeutics, Inc. is a pioneering biotechnology firm dedicated to advancing next-generation cell therapies for cancer treatment, primarily through its innovative proprietary platform designed to optimize natural killer (NK) cell therapies. With an extensive pipeline addressing both hematologic and solid tumors, the company is committed to enhancing the safety and effectiveness of immuno-oncology solutions. Artiva\u2019s strategy combines scientific rigor with strategic collaborations, positioning it as a notable participant in the rapidly evolving landscape of cancer therapeutics. As it progresses its promising candidates through clinical development, Artiva aims to revolutionize cancer care and improve patient outcomes.", "CIK": "1817241", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "5505 MOREHOUSE DRIVE, SAN DIEGO, CA, UNITED STATES, 92121", "OfficialSite": "https://www.artivabio.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "82803000", "EBITDA": "-79073000", "PERatio": "None", "PEGRatio": "None", "BookValue": "6.11", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-6.15", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.416", "ReturnOnEquityTTM": "-0.862", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-6.15", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-1", "AnalystTargetPrice": "17", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "5", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "214.51", "PriceToBookRatio": "0.76", "EVToRevenue": "7.54", "EVToEBITDA": "-", "Beta": "None", "52WeekHigh": "7.36", "52WeekLow": "1.47", "50DayMovingAverage": "3.375", "200DayMovingAverage": "3.038", "SharesOutstanding": "24425800", "SharesFloat": "5407100", "PercentInsiders": "19.875", "PercentInstitutions": "74.880", "DividendDate": "None", "ExDividendDate": "None"}